Choice Hotels International reports Q1 2026 earnings tomorrow morning with the borrow market for its shares at a breaking point — and 14% of the free float sitting short.
The lending picture is the sharpest signal right now. Availability has collapsed to just 0.25%, meaning virtually every share in the lending pool is already out on loan — the tightest the borrow has been for months. A week ago availability was nearly 13%. That 95% drop in a single week points to a sudden surge in demand for borrows, almost certainly tied to positioning into tomorrow's print. Cost to borrow, at 1.25%, is actually down over the month, which is worth noting: the borrow market is tight on quantity but not yet expensive, suggesting shorts are getting in before the door closes rather than paying up in a panic.
Short interest itself is high but off its worst levels. At roughly 19% of the free float — using ORTEX's estimated share count against available float data — the position is substantial. Yet over the past month it has fallen from a peak near 22% in mid-April, a meaningful reduction. The week-on-week move is a modest 1.6% increase in shares, so shorts are rebuilding incrementally rather than aggressively re-loading. The ORTEX short score is a punishing 81.5, running near the top of its recent range and placing CHH in the first percentile on days-to-cover rank — days to cover is reported at more than nine sessions, a reminder that unwinding this position against thin daily volume is genuinely painful.
Options traders have turned notably more relaxed heading into the event. The put/call ratio is 0.72, below its 20-day average of 0.79, which is a reversal of the defensive posture the stock carried through April, when PCR was running above 1.0 for much of the month. That shift from hedging to relative complacency in options — while the borrow market simultaneously drains — sets up an interesting asymmetry for tomorrow.
The Street is in cautious alignment. Multiple analysts trimmed targets after last quarter's brutal report, and none upgraded. Morgan Stanley held its Underweight at $86 as recently as May 12, a target nearly 20% below the current $106 price. JP Morgan's Neutral carries a $116 target, barely above the current level. Only Truist still carries a Buy with a $129 target — currently $23 above the stock. The mean price target is $112.53, which implies modest upside but the bear cases are sitting well below where the stock trades today. Valuation multiples add to the picture: the PE has contracted by more than 2 points over the past month to 14.3x, and EV/EBITDA has drifted lower, though price-to-book at 14.7x remains elevated.
The institutional register carries its own story. The Bainum family — founding shareholders — collectively represent more than 15% of the company across multiple members and the Realty Investment Company vehicle. Stewart Bainum trimmed 1.6 million shares as of late March, the largest single holder move in the register. Balyasny and Two Sigma both added meaningful new positions in Q1, suggesting active capital is taking a view either way. Most recent insider trades from management were clustered on March 2 and were entirely sells, with the CEO disposing of $2.4M worth at $104, close to current levels.
The last earnings event on April 30 delivered a -14% one-day move and a -9% five-day follow-through — the stock's worst single-day reaction in recent memory. Tomorrow's print is therefore less about whether Choice Hotels can grow its franchise count and more about whether Q1 RevPAR held up well enough to change a narrative that has left shorts very well paid and the closest comparable peer, WH, down 5.6% on the week while CHH has barely moved.
See the live data behind this article on ORTEX.
Open CHH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
